
Gyre Therapeutics, Inc.: shareholders and insiders
Price
$4.21
November 20, 2026Market cap $486M
What Ploutos Investor adds for Gyre Therapeutics
Part of Ploutos Investor, €9.99 a month
- The full history: 14 fiscal years, from 2009
- The estimated fair value, with its range and its certainty
- The full analysis, 18 a month
- More questions to the chat on its filings
- Excel with every year
- An email when it reports, changes its dividend or an officer buys
Sign in with a free account to see the last 5 fiscal years.
Insiders and their shares
Purchases and sales by officers and directors, from their own Form 4 filings.
Reading the newest filings from the SEC. This part fills in on its own in a few seconds.
Major holders (over 5%)
Whoever comes to own more than 5% of a class of shares reports it to the SEC on Schedule 13D or 13G. Here is each holder's latest filing.
- GNI USA, Inc.with 1 more personShare of class69.1%
- Ying Luowith 1 more personShare of class8.60%
- Songjiang Mawith 1 more personShare of class6.33%
| Holder | Kind of stake | Share of class | Shares | Filed | Filing |
|---|---|---|---|---|---|
| GNI USA, Inc.with 1 more person | 69.1% | 86.32M | May 6, 2026 | 13D/A | |
| Ying Luowith 1 more person | 8.60% | 10.21M | May 6, 2026 | 13D/A | |
| Songjiang Mawith 1 more person | 6.33% | 7.34M | May 7, 2026 | 13D/A |
What the holders on a 13D state as their purpose
From Item 4 of the filing, in the holder's own words. It is the intention the holder states, not something that happened.
GNI USA, Inc.69.1%From the filing of May 6, 2026
Item 4 of the Statement is hereby amended and supplemented as follows: Agreement and Plan of Merger On May 4, 2026 (the "Merger Closing Date"), Gyre consummated the previously announced acquisition of Cullgen Inc., a Delaware corporation ("Cullgen"), in accordance with the terms of the Agreement and Plan of Merger and Reorganization, dated March 2, 2026 (the "Merger Agreement"), by and among the Company, Helix Merger Sub Corp., a Delaware corporation and wholly owned subsidiary of the Company ("Merger Sub"), and Cullgen. Pursuant to the Merger Agreement, Merger Sub merged with and into Cullgen, with Cullgen continuing as a wholly owned subsidiary of the Company and the surviving…
From the filing of May 6, 2026Ying Luo8.6%From the filing of May 6, 2026
Item 4 of the Statement is hereby amended and supplemented as follows: Agreement and Plan of Merger On May 4, 2026 (the "Merger Closing Date"), Gyre consummated the previously announced acquisition of Cullgen Inc., a Delaware corporation ("Cullgen"), in accordance with the terms of the Agreement and Plan of Merger and Reorganization, dated March 2, 2026 (the "Merger Agreement"), by and among the Company, Helix Merger Sub Corp., a Delaware corporation and wholly owned subsidiary of the Company ("Merger Sub"), and Cullgen. Pursuant to the Merger Agreement, Merger Sub merged with and into Cullgen, with Cullgen continuing as a wholly owned subsidiary of the Company and the surviving…
From the filing of May 6, 2026Songjiang Ma6.3%From the filing of May 7, 2026
Item 4 of the Statement is hereby amended and supplemented as follows: Agreement and Plan of Merger On May 4, 2026 (the "Merger Closing Date"), Gyre consummated the previously announced acquisition of Cullgen Inc., a Delaware corporation ("Cullgen"), in accordance with the terms of the Agreement and Plan of Merger and Reorganization, dated March 2, 2026 (the "Merger Agreement"), by and among the Company, Helix Merger Sub Corp., a Delaware corporation and wholly owned subsidiary of the Company ("Merger Sub"), and Cullgen. Pursuant to the Merger Agreement, Merger Sub merged with and into Cullgen, with Cullgen continuing as a wholly owned subsidiary of the Company and the surviving…
From the filing of May 7, 2026
From the Schedule 13D and 13G filed with the SEC since Dec 18, 2024, when they became structured data. A holder who has filed nothing since then is not shown here. A 13D is updated within two business days of any material change, a 13G up to 45 days after the quarter of the change, so the shares are those of the filing. The large managers also appear in the 13Fs.
Well-known managers
Which of the about 30 investment managers we track held the shares at the quarter end, and what they changed from the quarter before.
- Millennium Mgmt (Englander)In the quarter+8.9%
| Manager | Shares | In the quarter | Value | % of their portfolio |
|---|---|---|---|---|
| Millennium Mgmt (Englander) | 20.1K | +8.9% | $100.0K | 0.00% |
From the 13Fs managers file with the SEC up to 45 days after each quarter end. They show only long positions on that day, not short sales or what has changed since. No recent 13F: Pershing Square (Ackman), Scion (Burry).
Short interest
How many of the company's shares have been sold borrowed and not yet bought back, twice a month.
On Oct 15, 2026, 1.67% of its shares outstanding were held short, +0.5% since the report before.
- Shares held short
- 1.93M
- 1.67%
- Since the report before1.92M on Sep 30, 2026
- +0.5%
- 16.3
- 118.3K
- More days to cover thanof 4,578 US-listed companies with enough volume
- 99%
- Report date
- Oct 15, 2026
- Shares held short
- Oct 31, 2023: Shares held short 81.6K
- Nov 15, 2023: Shares held short 48.8K
- Nov 30, 2023: Shares held short 265.5K
- Dec 15, 2023: Shares held short 204.4K
- Dec 29, 2023: Shares held short 305.8K
- Jan 12, 2024: Shares held short 236.1K
- Jan 31, 2024: Shares held short 210.0K
- Feb 15, 2024: Shares held short 156.3K
- Feb 29, 2024: Shares held short 139.7K
- Mar 15, 2024: Shares held short 125.2K
- Mar 28, 2024: Shares held short 121.2K
- Apr 15, 2024: Shares held short 181.9K
- Apr 30, 2024: Shares held short 76.1K
- May 15, 2024: Shares held short 169.6K
- May 31, 2024: Shares held short 203.3K
- Jun 14, 2024: Shares held short 189.1K
- Jun 28, 2024: Shares held short 173.6K
- Jul 15, 2024: Shares held short 291.5K
- Jul 31, 2024: Shares held short 319.3K
- Aug 15, 2024: Shares held short 336.5K
- Aug 30, 2024: Shares held short 313.0K
- Sep 13, 2024: Shares held short 308.4K
- Sep 30, 2024: Shares held short 457.3K
- Oct 15, 2024: Shares held short 448.7K
- Oct 31, 2024: Shares held short 376.6K
- Nov 15, 2024: Shares held short 401.7K
- Nov 29, 2024: Shares held short 549.4K
- Dec 13, 2024: Shares held short 832.1K
- Dec 31, 2024: Shares held short 952.3K
- Jan 15, 2025: Shares held short 1.26M
- Jan 31, 2025: Shares held short 1.25M
- Feb 14, 2025: Shares held short 1.25M
- Feb 28, 2025: Shares held short 1.35M
- Mar 14, 2025: Shares held short 1.53M
- Mar 31, 2025: Shares held short 2.39M
- Apr 15, 2025: Shares held short 2.50M
- Apr 30, 2025: Shares held short 2.37M
- May 15, 2025: Shares held short 2.48M
- May 30, 2025: Shares held short 1.42M
- Jun 13, 2025: Shares held short 1.41M
- Jun 30, 2025: Shares held short 1.80M
- Jul 15, 2025: Shares held short 1.81M
- Jul 31, 2025: Shares held short 1.85M
- Aug 15, 2025: Shares held short 1.77M
- Aug 29, 2025: Shares held short 1.74M
- Sep 15, 2025: Shares held short 1.62M
- Sep 30, 2025: Shares held short 1.67M
- Oct 15, 2025: Shares held short 1.50M
- Oct 31, 2025: Shares held short 1.54M
- Nov 14, 2025: Shares held short 1.48M
- Nov 28, 2025: Shares held short 1.47M
- Dec 15, 2025: Shares held short 1.38M
- Dec 31, 2025: Shares held short 1.38M
- Jan 15, 2026: Shares held short 1.49M
- Jan 30, 2026: Shares held short 1.42M
- Feb 13, 2026: Shares held short 1.48M
- Feb 27, 2026: Shares held short 1.34M
- Mar 13, 2026: Shares held short 1.38M
- Mar 31, 2026: Shares held short 1.53M
- Apr 15, 2026: Shares held short 1.58M
- Apr 30, 2026: Shares held short 1.58M
- May 15, 2026: Shares held short 1.68M
- May 29, 2026: Shares held short 1.67M
- Jun 15, 2026: Shares held short 1.74M
- Jun 30, 2026: Shares held short 1.83M
- Jul 15, 2026: Shares held short 2.04M
- Jul 31, 2026: Shares held short 1.82M
- Aug 14, 2026: Shares held short 1.75M
- Aug 31, 2026: Shares held short 1.71M
- Sep 15, 2026: Shares held short 1.73M
- Sep 30, 2026: Shares held short 1.92M
- Oct 15, 2026: Shares held short 1.93M
As brokers report them to the regulator twice a month, mid-month and at month end, published about eight business days later. A short position is shares sold borrowed and not yet bought back. The share count is the one the company's market value is figured on, from its filings. Days to cover is the shares held short over the average daily volume of the weeks between two reports.
Short sales in daily trading62.3% of the shares in the last 14 sessions' reported trades were short sales.
In the last 14 sessions, 62.3% of the shares in the reported trades were short sales, against 69.6% in the 14 before.
- Last 14 sessionsNov 3, 2026 – Nov 20, 2026
- 62.3%
- The 14 beforeOct 14, 2026 – Nov 2, 2026
- 69.6%
- Change
- -7.3 pts
- Short sales a dayon average, of 93.7K shares
- 58.4K
- More than atof 3,666 US-listed companies, same days
- 87%
- Median of alleight in ten from 34.4% to 63.9%
- 50.5%
- Short sales
- Oct 14, 2026: Short sales 73.1%
- Oct 15, 2026: Short sales 85.9%
- Oct 16, 2026: Short sales 76.3%
- Oct 19, 2026: Short sales 70.1%
- Oct 20, 2026: Short sales 39.1%
- Oct 21, 2026: Short sales 61.9%
- Oct 22, 2026: Short sales 59.7%
- Oct 23, 2026: Short sales 71.3%
- Oct 26, 2026: Short sales 74.6%
- Oct 27, 2026: Short sales 41.9%
- Oct 28, 2026: Short sales 77.4%
- Oct 29, 2026: Short sales 62.6%
- Oct 30, 2026: Short sales 64%
- Nov 2, 2026: Short sales 82.4%
- Nov 3, 2026: Short sales 77.3%
- Nov 4, 2026: Short sales 54.1%
- Nov 5, 2026: Short sales 61.7%
- Nov 6, 2026: Short sales 46.3%
- Nov 9, 2026: Short sales 56.1%
- Nov 10, 2026: Short sales 72.5%
- Nov 11, 2026: Short sales 71.5%
- Nov 12, 2026: Short sales 62%
- Nov 13, 2026: Short sales 76.2%
- Nov 16, 2026: Short sales 52.9%
- Nov 17, 2026: Short sales 63.9%
- Nov 18, 2026: Short sales 67.8%
- Nov 19, 2026: Short sales 64.6%
- Nov 20, 2026: Short sales 76.8%
This is not the number of shares sold short today: it measures short sales within each day's trading, and only trades made off the exchanges. Much of it is market makers, who sell shares they do not have to fill buyers' orders and cover soon after, so for a heavily traded stock the share is often around half.
The ETFs that hold it
Which of the 349 US equity ETFs we track hold the stock, and at what weight, from the funds' N-PORT filings.
- IWOiShares Russell 2000 Growth ETFWeight in the fund0.01%
- VTWOVanguard Russell 2000 Index FundWeight in the fund0.00%
- IWMiShares Russell 2000 ETFWeight in the fund0.00%
- SCHASchwab U.S. Small-Cap ETFWeight in the fund0.00%
- IWNiShares Russell 2000 Value ETFWeight in the fund0.00%
- VXFVanguard Extended Market Index FundWeight in the fund0.00%
- SCHBSchwab U.S. Broad Market ETFWeight in the fund0.00%
- VTIVanguard Total Stock Market Index FundWeight in the fund0.00%
8 of the 349 ETFs we track, not of every ETF on the market. The ten largest weights. Positions as each fund filed them in its latest N-PORT.
Institutional investors by quarter
Every manager that reports positions to the SEC (Form 13F), quarter by quarter: how many hold the stock, how many shares and dollars between them, and who entered, left, added or trimmed during the quarter.
- Managers
- Q3 2025: Managers 48
- Q4 2025: Managers 44
- Q1 2026: Managers 56
- Q2 2026: Managers 60
Institutional investors by quarter
The fund managers holding GYRE, quarter by quarter, from Q4 2023 to Q2 2025, 7 more quarters
Part of Ploutos Investor, €9.99 a month
Sign in with a free account to see the last 11 quarters.
Q2 2026: 60 managers held 8.67M shares, worth $57M. During the quarter 12 opened a position, 8 closed one, 29 added and 9 trimmed.
The largest holders, Q2 2026
- HSG HoldingIn the quarter
- BlackRockIn the quarter+31%
- Octagon Capital AdvisorsIn the quarter
- Vanguard Capital ManagementIn the quarter-11%
- Geode Capital ManagementIn the quarter+24%
- State StreetIn the quarter+13%
- Charles Schwab Investment ManagementIn the quarter+12%
- Northern TrustIn the quarter+27%
- SBI SecuritiesIn the quarter-2.4%
- Vanguard Fiduciary TrustIn the quarter+9.7%
| Manager | Shares | In the quarter | Value |
|---|---|---|---|
| HSG Holding | 3.75M | $25M | |
| BlackRock | 993.9K | +31% | $6.6M |
| Octagon Capital Advisors | 954.4K | $6.3M | |
| Vanguard Capital Management | 876.9K | -11% | $5.8M |
| Geode Capital Management | 533.0K | +24% | $3.5M |
| State Street | 245.4K | +13% | $1.6M |
| Charles Schwab Investment Management | 184.3K | +12% | $1.2M |
| Northern Trust | 169.5K | +27% | $1.1M |
| SBI Securities | 166.8K | -2.4% | $1.1M |
| Vanguard Fiduciary Trust | 151.1K | +9.7% | $995.6K |
From the SEC's Form 13F data sets, Q3 2025 to Q2 2026: the long positions of every manager with more than $100 million under management, as filed up to 45 days after each quarter end. Short positions and options are not in them. Shares as reported each quarter, not adjusted for splits. The stock is matched by its CUSIP, through the SEC's fails-to-deliver files.
Pay against performance, the say-on-pay vote, buybacks by quarter and trading plans are read for S&P 500 companies only.
The full analysis
What do Gyre Therapeutics's filings show?
Who buys and sells is one part of Gyre Therapeutics's picture. The full Ploutos AI analysis reads everything the company has filed and shows what stands behind it, with a source for every figure.
- A fair value range built from the filings
- Earnings quality, debt and red flags
- Insider and institutional moves
- The case for and the case against
Which well-known managers hold GYRE?
1 of the managers we track held the shares on Sep 30, 2026. The largest position was Millennium Mgmt (Englander)'s, worth $100.0K.
Is every insider transaction a purchase or a sale?
No. Many are part of their pay: share awards, option exercises and shares the company keeps for the tax. Only code P is a purchase with their own money, and code S a sale on the market.
Related pages
The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.
The figures come from the company's SEC filings and the share price, and describe what it has reported. They are not a score or a fair value.